ABC Arbitrage SA bought a new stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 197,206 shares of the medical equipment provider’s stock, valued at approximately $4,847,000.
A number of other large investors have also recently made changes to their positions in SNN. R Squared Ltd purchased a new position in shares of Smith & Nephew in the 4th quarter valued at $41,000. GAMMA Investing LLC grew its stake in shares of Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after purchasing an additional 718 shares during the period. Allspring Global Investments Holdings LLC increased its stake in shares of Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock valued at $94,000 after purchasing an additional 1,290 shares in the last quarter. Blue Trust Inc. grew its position in shares of Smith & Nephew by 26.0% in the fourth quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider’s stock valued at $144,000 after purchasing an additional 1,213 shares during the period. Finally, Coerente Capital Management purchased a new stake in Smith & Nephew during the 3rd quarter worth approximately $202,000. 25.64% of the stock is owned by hedge funds and other institutional investors.
Smith & Nephew Trading Up 0.0 %
Shares of NYSE SNN opened at $25.72 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The stock’s 50-day moving average is $25.02 and its two-hundred day moving average is $27.45. Smith & Nephew plc has a 1-year low of $23.65 and a 1-year high of $31.72.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on Smith & Nephew
Smith & Nephew Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.
See Also
- Five stocks we like better than Smith & Nephew
- Why Are These Companies Considered Blue Chips?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What is the S&P 500 and How It is Distinct from Other Indexes
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- 3 Fintech Stocks With Good 2021 Prospects
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN – Free Report).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.